{"slideshow_credits": null, "snippet": "The investigation is related to Martin Shkreli's time as a hedge fund manager and running the biopharmaceutical company Retrophin.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "multimedia", "byline": [], "web_url": "http://www.nytimes.com/interactive/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud.html", "lead_paragraph": "The investigation is related to Martin Shkreli's time as a hedge fund manager and running the biopharmaceutical company Retrophin.", "headline": {"main": "Indictment Charges Shkreli With Security Fraud"}, "_id": "5672e0bd38f0d82eed76c6ce", "word_count": null, "multimedia": [{"height": 126, "url": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-thumbWide-v3.png", "legacy": {"wideheight": "126", "wide": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-thumbWide-v3.png", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-articleLarge-v3.png", "legacy": {"xlarge": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-articleLarge-v3.png", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-thumbStandard-v3.png", "legacy": {"thumbnail": "images/2015/12/17/business/document-indictment-charges-shkreli-with-security-fraud/document-indictment-charges-shkreli-with-security-fraud-thumbStandard-v3.png", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business Day", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Hedge Funds", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Frauds and Swindling", "is_major": "N", "rank": "3"}, {"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Interactive Feature"}